New approaches to respiratory infections in children. Bronchiolitis and croup

Robert Bruce Wright1, Wendy J Pomerantz, Joseph W Luria

  • 1Division of Emergency Medicine, Children's Hospital Medical Center, Cincinnati, Ohio, USA. bruce.wright@chmcc.org

Insights

Croup, a common childhood respiratory illness, is often treated with supportive care. Steroids like dexamethasone improve outcomes for mild to moderate cases, while epinephrine can manage severe symptoms, potentially avoiding hospitalization.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Emergency Medicine

Background:

  • Croup is a common viral respiratory illness in children under 6.
  • Parainfluenza viruses and RSV are frequent causes.
  • Initial home treatments like humidification are often insufficient for moderate to severe cases presenting to the Emergency Department (ED).

Purpose of the Study:

  • To outline current treatment strategies for croup in pediatric patients.
  • To highlight the efficacy of specific medications in managing croup symptoms.
  • To define criteria for safe discharge after ED treatment for severe croup.

Main Methods:

  • Review of established treatment protocols for viral croup.
  • Discussion of pharmacologic interventions including corticosteroids and epinephrine.
  • Analysis of observation periods and discharge criteria following acute treatment.

Main Results:

  • Oral dexamethasone (0.15-0.6 mg/kg) improves outpatient outcomes for mild to moderate croup, reducing hospitalizations.
  • Nebulized budesonide is an alternative steroid treatment.
  • Racemic or L-epinephrine effectively treats severe croup symptoms, allowing safe ED discharge after 3 hours of observation if asymptomatic.

Conclusions:

  • Corticosteroids are beneficial for mild to moderate croup.
  • Epinephrine administration in severe croup does not necessitate automatic hospitalization.
  • Careful observation and access to follow-up care enable safe discharge for severe croup patients post-treatment.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...